Prothena’s (PRTA) Overweight Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of Prothena (NASDAQ:PRTA – Free Report) in a research report report published on Friday,Benzinga reports. A number of other equities research analysts have also recently commented on PRTA. HC Wainwright restated a “buy” rating and issued a $48.00 price target on shares of Prothena in a report […]
Cantor Fitzgerald reissued their overweight rating on shares of Prothena (NASDAQ:PRTA – Free Report) in a research report report published on Friday,Benzinga reports. A number of other equities research analysts have also recently commented on PRTA. HC Wainwright restated a “buy” rating and issued a $48.00 price target on shares of Prothena in a report […]
